>Sharp rise in volumes at GPN in Q4, underpinned by A&P investments - Organic growth for of 4.8% for GPN was fuelled by a price effect of 5.4%. Volumes were down slightly (-0.6%), resulting in a 17.2%e volume recovery in Q4, underpinned by marketing investment and promotions linked to protein products. Prices fell by 5.9% in Q4. The ON brand (62% of sales) grew by 17%, including +10.6% in volume, as USA consumption remained buoyant (+14%). The SlimFast brand (9% of sa...
>Forte hausse des volumes de GPN au T4, soutenus par les investissements A&P - La croissance organique de GPN de 4.8% est tirée par un effet prix de 5.4%. Les volumes baissent légèrement de 0.6% se traduisant par un rebond de 17.2%e au T4, soutenu par des investissements marketing et les promotions sur les produits protéinés. Les prix baissent de 5.9% au T4. La marque ON (62% du CA) croit de 17% dont +10.6% en volume, la consommation aux USA reste dynamique (+14%). La...
>Organic sales growth of -8.2% (vs css -8.8%) hit by pricing, while EBITA margin is in line at 7.8% - Glanbia reported sales of $ 5.4bn in 2023, which is next to estimates. Organic sales came in at -8.2%, better than the consensus forecast and below ours on lower pricing for Glanbia Nutrition. GPN delivered +4.8% in line with expectations, driving by pricing. The decline in volumes is mainly driven by the SlimFast brand in the US. ON brand is growing by 17% both in v...
>Organic sales growth of -8.2% (vs css -8.8%) hit by pricing, while EBITA margin is in line at 7.8% - Glanbia reported sales of $ 5.4bn in 2023, which is next to estimates. Organic sales came in at -8.2%, better than the consensus forecast and below ours on lower pricing for Glanbia Nutrition. GPN delivered +4.8% in line with expectations, driving by pricing. The decline in volumes is mainly driven by the SlimFast brand in the US. ON brand is growing by 17% both in v...
>Glanbia Performance Nutrition: organic sales growth expected to reach 5%, driven by price effects. Volume recovery forecast for Q4 - The Q4 volumes for GPN should recover, underpinned by the marketing investments and promotional offers on some ranges, notably in the US (Black Friday, Amazon Prime Day). However, the SlimFast brand (10% of GPN’s sales) should remain down in Q4, still penalised by a tough slimming market and a reduction in collections on US retailers’ ...
>Glanbia Performance Nutrition : la croissance organique du CA devrait atteindre 5%, tirée par les effets prix. Redressement attendu des volumes au T4 - Les volumes du T4 de GPN devraient se redresser, soutenus par les investissements marketing et les opérations promotionnelles sur certaines gammes notamment aux USA (Black Friday, Amazone prime day). En revanche, la marque SlimFast (10% du CA de GPN) devrait rester en retrait sur le T4, encore pénalisée par un marché...
Summary Marketline's Kerry Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Kerry Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments rep...
Summary Ornua Co-operative Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Ornua Co-operative Ltd (Ornua) is a dairy commercial co-operative enterprise. The company offers a wide range of dairy products including butter, cheese, whole and skimmed milk, milk powders, cas...
>GPN : amélioration de la guidance de marge grâce à un meilleur mix attendu - La croissance organique des 9 mois de GPN de 2.7% reflète un retrait de 1.8% en zone Amériques, compensé par une solide progression à l’international de 12.3%. Le recul de ventes de Slimfast (-34% vs -31% au S1) continue de peser sur l’activité au T3 dans un marché de l’amincissement US compliqué et concurrentiel. Les produits ON continuent de progresser de 12.5% soutenue par les hausses de ...
>GPN: margin guidance improved thanks to better mix expected - 9-month organic growth for GPN was 2.7% reflecting a fall of -1.8% in the Americas, offset by solid growth on international markets of 12.3%. The fall in Slimfast sales (-34% vs -31% in H1) continued to weigh on activity in Q3 in a complicated and competitive US weight management market. ON products continued to grow, rising 12.5%, supported by the price hikes introduced in 2022 and also by good volume res...
>The increase in GPN’s margin guidance is due to the drop in raw material prices and a positive trend expected in the product mix - The increase in the guidance for FY EPS growth to 12-15% is due mainly to better profitability expected for GPN. The group forecasts a margin at 13.5-14.5% (vs 12.5-13% previously). This margin upgrade, which accounts for a rise in marketing costs this year, is due to: 1/ a fall in raw materials costs (whey), and; 2/ a better trend expect...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.